# Comparison of Oral Semaglutide w/ Placebo- Treatment for Latino Adults w/T2 Diabetes Receiving Enhanced Lifestyle Care

> **NCT04938388** · PHASE4 · TERMINATED · sponsor: **Sansum Diabetes Research Institute** · enrollment: 12 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2
- Glucose Metabolism Disorders (Including Diabetes Mellitus)

## Interventions

- **DRUG:** Semaglutide Pill
- **DIETARY_SUPPLEMENT:** Fresh organic vegetables

## Key facts

- **NCT ID:** NCT04938388
- **Lead sponsor:** Sansum Diabetes Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2022-01-29
- **Primary completion:** 2023-02-16
- **Final completion:** 2023-02-16
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** Principal Investigator no longer at study site.
- **Last updated:** 2023-05-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04938388

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04938388, "Comparison of Oral Semaglutide w/ Placebo- Treatment for Latino Adults w/T2 Diabetes Receiving Enhanced Lifestyle Care". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT04938388. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*